Eledon Pharmaceuticals (ELDN) Other Operating Expenses (2016 - 2025)

Eledon Pharmaceuticals has reported Other Operating Expenses for 6 years, with the latest figure at -$54.3 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses rose 15.21% year-over-year to -$54.3 million; the trailing twelve-month figure through Mar 2026 stood at -$54.3 million (up 15.21% YoY), and the FY2025 full-year result was $7.5 million, up 111.67% from the prior year.
• Other Operating Expenses for Q4 2025 stood at -$54.3 million, up from -$64.0 million in the prior quarter.
• The five-year high for Other Operating Expenses was $48.6 million in Q4 2022, with the low at -$64.0 million in Q4 2024.
• Historically, Other Operating Expenses has averaged -$23.2 million across 3 years, with a median of -$54.3 million in 2025.
• The largest YoY upside for Other Operating Expenses was 15.21% in 2025 against a maximum downside of 15.21% in 2025.
• Eledon Pharmaceuticals' Other Operating Expenses stood at $48.6 million in 2022, then plunged by 231.63% to -$64.0 million in 2024, then advanced by 15.21% to -$54.3 million in 2025.
• The last three Other Operating Expenses figures came in at -$54.3 million (Q4 2025), -$64.0 million (Q4 2024), and $48.6 million (Q4 2022), per Business Quant data.